These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 21892212)

  • 1. IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD.
    Jol-van der Zijde CM; Bredius RG; Jansen-Hoogendijk AM; Raaijmakers S; Egeler RM; Lankester AC; van Tol MJ
    Bone Marrow Transplant; 2012 Mar; 47(3):360-8. PubMed ID: 21892212
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rabbit-immunoglobulin G levels in patients receiving thymoglobulin as part of conditioning before unrelated donor stem cell transplantation.
    Remberger M; Sundberg B
    Haematologica; 2005 Jul; 90(7):931-8. PubMed ID: 15996931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Unrelated donor stem cell transplantation in children: low toxicity using a GvHD-prophylaxis regimen with CSA, MTX, metronidazole,iv-immunoglobulin and ATG].
    Graf Finckenstein F; Zabelina T; Dürken M; Dahlke J; Kröger N; Krüger W; Janka-Schaub G; Erttmann R; Zander AR; Kabisch H
    Klin Padiatr; 2002; 214(4):206-11. PubMed ID: 12165903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Favorable effects of low-dose anti-thymocyte globulin in a partially-mismatched HLA group in an unrelated allogeneic stem cell transplantation setting.
    Sohn SK; Moon JH
    Ann Transplant; 2015 Jan; 20():7-15. PubMed ID: 25564881
    [TBL] [Abstract][Full Text] [Related]  

  • 5. High rabbit-antihuman thymocyte globulin levels are associated with low likelihood of graft-vs-host disease and high likelihood of posttransplant lymphoproliferative disorder.
    Podgorny PJ; Ugarte-Torres A; Liu Y; Williamson TS; Russell JA; Storek J
    Biol Blood Marrow Transplant; 2010 Jul; 16(7):915-26. PubMed ID: 20226870
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effects of Campath 1H upon graft-versus-host disease, infection, relapse, and immune reconstitution in recipients of pediatric unrelated transplants.
    Shah AJ; Kapoor N; Crooks GM; Weinberg KI; Azim HA; Killen R; Kuo L; Rushing T; Kohn DB; Parkman R
    Biol Blood Marrow Transplant; 2007 May; 13(5):584-93. PubMed ID: 17448918
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antithymocyte globulins and chronic graft-vs-host disease after myeloablative allogeneic stem cell transplantation from HLA-matched unrelated donors: a report from the Sociéte Française de Greffe de Moelle et de Thérapie Cellulaire.
    Mohty M; Labopin M; Balère ML; Socié G; Milpied N; Tabrizi R; Ifrah N; Hicheri Y; Dhedin N; Michallet M; Buzyn A; Cahn JY; Bourhis JH; Blaise D; Raffoux C; Espérou H; Yakoub-Agha I
    Leukemia; 2010 Nov; 24(11):1867-74. PubMed ID: 20882046
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hypogammaglobulinemia in children after allogeneic hematopoietic stem cell transplantation: a cytokine mediated immunoglobulin isotype class switch arrest?
    Sundin M; Remberger M; Lindqvist H; Omazic B; Sundberg B; Uzunel M; Winiarski J
    Pediatr Blood Cancer; 2015 May; 62(5):890-6. PubMed ID: 25623620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rabbit anti-T-lymphocyte globulin (ATG) persists with differential reactivity in patients' sera after full hematopoetic regeneration from allogeneic stem cell transplantation.
    Ziegler C; Finke J; Grüllich C
    Transpl Immunol; 2014 May; 30(4):136-9. PubMed ID: 24727089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of different serum-levels of ATG after unrelated donor umbilical cord blood transplantation.
    Remberger M; Persson M; Mattsson J; Gustafsson B; Uhlin M
    Transpl Immunol; 2012 Aug; 27(1):59-62. PubMed ID: 22709940
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Low serum levels of total rabbit-IgG is associated with acute graft-versus-host disease after unrelated donor hematopoietic stem cell transplantation: results from a prospective study.
    Remberger M; Sundberg B
    Biol Blood Marrow Transplant; 2009 Aug; 15(8):996-9. PubMed ID: 19589490
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antithymocyte globulin affects the occurrence of acute and chronic graft-versus-host disease after a reduced-intensity conditioning regimen by modulating mixed chimerism induction and immune reconstitution.
    Nakai K; Mineishi S; Kami M; Saito T; Hori A; Kojima R; Imataki O; Hamaki T; Yoshihara S; Ohnishi M; Kim SW; Ando T; Fumitoh A; Kanda Y; Makimoto A; Tanosaki R; Kanai S; Heike Y; Ohnishi T; Kawano Y; Wakasugi H; Takaue Y
    Transplantation; 2003 Jun; 75(12):2135-43. PubMed ID: 12829926
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A high antithymocyte globulin dose increases the risk of relapse after reduced intensity conditioning HSCT with unrelated donors.
    Remberger M; Ringdén O; Hägglund H; Svahn BM; Ljungman P; Uhlin M; Mattsson J
    Clin Transplant; 2013; 27(4):E368-74. PubMed ID: 23701240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity as therapeutic principle in the treatment of hematologic malignancies. Studies of clinical and immunologic aspects of allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning.
    Petersen SL
    Dan Med Bull; 2007 May; 54(2):112-39. PubMed ID: 17521527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Antibodies to 60, 65 and 70 kDa heat shock proteins in pediatric allogeneic stem cell transplant recipients.
    Zlacka D; Sedlacek P; Prucha M; Hromadnikova I
    Pediatr Transplant; 2006 Nov; 10(7):794-804. PubMed ID: 17032425
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of matched sibling donor hematopoietic stem cell transplantation for severe sickle cell disease with myeloablative conditioning and intermediate-dose of rabbit anti-thymocyte globulin.
    Soni S; Gross TG; Rangarajan H; Baker KS; Sturm M; Rhodes M
    Pediatr Blood Cancer; 2014 Sep; 61(9):1685-9. PubMed ID: 24740582
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of antithymocyte globulin and granulocyte-colony stimulating factor-mobilized bone marrow in allogeneic transplantation for patients with hematologic malignancies.
    Chen XH; Zhang C; Zhang X; Gao L; Gao L; Kong PY; Peng XG; Qi DG; Sun AH; Zeng DF; Liu H; Gong Y; Wang QY
    Biol Blood Marrow Transplant; 2009 Feb; 15(2):266-73. PubMed ID: 19167687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo T cell depletion with low-dose rabbit antithymocyte globulin results in low transplant-related mortality and low relapse incidence following unrelated hematopoietic stem cell transplantation.
    Nachbaur D; Eibl B; Kropshofer G; Meister B; Mitterschiffthaler A; Schennach H; Fischer G; Kopp M; Gunsilius E; Gastl G
    J Hematother Stem Cell Res; 2002 Aug; 11(4):731-7. PubMed ID: 12201962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Matched and mismatched allogeneic stem-cell transplantation from unrelated donors using combined graft-versus-host disease prophylaxis including rabbit anti-T lymphocyte globulin.
    Finke J; Schmoor C; Lang H; Potthoff K; Bertz H
    J Clin Oncol; 2003 Feb; 21(3):506-13. PubMed ID: 12560442
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect on cytokine release and graft-versus-host disease of different anti-T cell antibodies during conditioning for unrelated haematopoietic stem cell transplantation.
    Remberger M; Svahn BM; Hentschke P; Löfgren C; Ringdén O
    Bone Marrow Transplant; 1999 Oct; 24(8):823-30. PubMed ID: 10516691
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.